Financial Reports Latest Updates Industry Maps Economic Calendar

Orthofix Medical Inc. (OFIX) Annual Reports

Q: Where can I read Orthofix Medical Inc. (OFIX) annual reports?

Every year on this page links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser. 3 filings are currently indexed.

Q: What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer; a 20-F is filed by foreign private issuers (Taiwanese companies with US ADRs, such as TSMC, file 20-F). A 40-F applies to Canadian issuers under the MJDS.

Orthofix Medical Inc. is listed on Nasdaq, classified by the SEC under Surgical & Medical Instruments & Apparatus (SIC 3841). This page indexes 3 annual reports, each linking to the full text on the SEC's EDGAR system.

Company profile

Exchange： Nasdaq
Fiscal year end： 12/23
SEC CIK： 884624 →

Website：Official site ↗

Financial Highlights

FY2026 Q2 (quarterly, ended 2026-06-30)
	Current	Prior year	YoY
Revenue	$210.9M	$203.1M	+3.8%
Operating income	$-8.1M	$-16.0M	+49.2%
Net income	$-15.8M	$-14.1M	-12.2%
EPS (diluted)	$-0.39	$-0.36	-8.3%

Source: SEC EDGAR (XBRL company facts)

Financial history

Revenue & profit

Quarterly · In mn (USD)

Revenue 211 mn Net income -15.8 mn

Show table：Income statement

Item	2009Q4	2010Q1	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Revenue	546	139	143	139	144	139	144	145	152	143	119	115	112	100	98.3	92.7	106	101	101	101	100	89.8	101	101	105	98.7	104	98.5	109	103	109	105	117	109	112	112	121	109	116	114	121	105	73.1	111	118	106	121	112	125	106	118	114	122	175	187	184	200	189	199	197	216	194	203	206	220	197	211
Gross profit	407	106	109	107	111	106	109	109	116	110	95.8	92.4	93.5	77.6	78.0	68.8	73.6	78.7	75.6	75.7	78.8	70.4	79.0	77.3	83.2	76.5	81.6	78.6	85.2	80.2	85.8	81.5	93.3	84.6	88.7	87.7	95.5	85.4	90.0	88.6	95.3	81.4	50.0	84.7	88.5	79.7	94.0	84.1	91.8	78.1	86.5	83.4	89.2	110	120	120	137	127	135	135	149	122	140	149	156	140	150
Operating income	63.9	—	21.2	19.0	16.8	-26.1	18.6	23.0	8.17	22.0	20.6	21.5	25.6	4.02	8.80	-15.6	6.38	2.47	6.70	6.51	3.95	-7.19	4.93	4.14	7.38	7.13	-2.64	9.27	7.42	5.92	8.00	9.03	17.9	7.87	7.02	3.91	12.4	-4.45	0.45	-18.9	4.10	6.85	-21.0	4.18	3.71	-2.92	4.27	-0.31	-9.35	-3.08	6.64	-5.79	-11.0	-59.7	-36.6	-24.4	-18.3	-29.3	-24.9	-18.9	-11.5	-48.9	-16.0	-17.1	0.49	-14.4	-8.13
Net income	—	17.5	10.2	8.52	7.96	-35.8	9.96	12.4	12.4	12.0	11.2	7.56	20.5	2.12	-2.32	-19.8	-7.88	-0.78	-0.68	0.45	-5.80	-8.38	3.57	-1.37	3.37	3.89	-7.39	9.90	-3.24	-2.65	3.85	3.46	1.57	5.23	0.93	-1.21	8.87	0.9	-0.55	-40.5	11.7	25.7	-18.4	4.65	-9.38	-5.82	2.42	-2.17	-32.8	-4.46	2.49	-10.7	-7.06	-60.9	-39.4	-28.9	-22.2	-36.0	-33.4	-27.4	-29.1	-53.1	-14.1	-22.8	-2.22	-20.9	-15.8

Balance sheet

Quarterly · In mn (USD)

Total assets 873 mn Total liabilities 444 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2009Q4	2010Q1	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Current assets	—	—	—	—	312	—	346	360	405	415	396	405	340	337	296	282	280	278	293	270	256	235	235	245	212	174	178	185	194	187	199	213	252	263	237	245	245	224	233	238	261	240	344	255	270	263	258	260	270	255	255	247	256	410	399	394	420	399	386	386	433	390	396	394	417	462	446
Total assets	—	—	—	—	604	619	647	656	696	708	553	565	504	503	459	430	423	419	434	411	393	387	389	402	400	363	365	376	372	355	368	386	405	409	442	450	467	479	489	476	496	493	596	517	526	514	502	500	477	462	462	450	459	917	901	906	925	906	882	868	893	823	837	833	851	887	873
Current liabilities	—	—	—	—	83.5	—	133	137	175	172	146	152	68.8	65.5	71.6	66.0	66.8	55.5	83.1	81.4	66.4	69.4	64.9	78.6	82.0	59.0	77.2	83.3	83.4	62.9	65.1	74.1	79.4	65.2	63.9	76.8	85.9	63.6	68.0	88.5	84.9	66.0	89.6	93.4	104	99.1	81.7	80.0	106	88.2	81.1	77.7	83.6	138	142	153	165	151	156	162	169	144	148	160	170	161	157
Total liabilities	—	—	—	—	303	355	349	345	380	369	199	187	105	101	114	111	113	101	129	106	93.6	96.2	91.5	105	110	87.3	107	103	109	87.6	90.7	101	109	95.8	122	127	131	136	141	169	168	138	251	162	169	159	140	136	140	126	120	116	122	253	261	290	327	336	336	342	390	365	379	390	401	451	444
Equity	240	—	—	—	301	264	298	311	315	338	354	378	399	402	345	319	310	317	305	305	300	291	298	297	290	275	258	273	263	267	277	285	297	313	320	323	335	344	348	306	328	355	345	355	357	355	362	365	337	336	342	334	337	664	640	615	599	570	546	526	503	458	458	442	450	435	429

Cash flow

Quarterly · In mn (USD)

Operating -6.22 mn Investing -12.7 mn Financing 2.45 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2009Q4	2010Q1	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Operating	50.6	—	19.6	10.2	12.8	18.8	4.62	16.2	25.2	49.0	8.79	10.6	-57.2	15.4	18.7	17.8	15.1	-10.2	-7.70	53.8	15.0	2.54	6.41	17.3	17.0	4.42	16.8	17.1	6.31	3.47	6.26	13.8	29.9	-3.56	16.6	15.8	21.1	-1.04	9.38	11.8	11.9	12.5	17.6	21.9	22.3	2.44	-2.18	6.43	11.8	-7.71	-4.91	-1.26	2.35	-34.0	-5.52	0.48	-6.69	-18.6	8.98	11.7	23.7	-18.4	11.6	12.4	27.7	-17.6	-6.22
Investing	-22.3	—	12.3	-5.28	-9.20	-10.9	-5.64	-6.02	-8.44	-6.52	147	-4.94	-10.1	-6.47	-7.01	-10.5	-7.10	-3.74	-2.49	-6.69	-7.03	-15.6	-8.46	-7.62	-6.70	-7.40	-6.57	-3.90	-4.07	-3.43	-4.69	-4.70	-3.66	-4.65	-46.9	-4.37	-5.08	-11.3	-5.42	-4.54	-1.64	-24.2	-4.39	-14.4	-9.39	-4.78	-5.01	-4.24	-8.98	-5.67	-7.49	-5.47	-5.90	17.1	-12.8	-22.3	-15.1	-10.9	-9.72	-5.86	-1.13	-6.74	-7.10	-9.89	-10.9	-10.5	-12.7
Financing	-29.9	—	-24.6	-10.2	-5.19	1.82	4.93	-8.23	-12.2	-28.9	-152	-2.36	44.6	-5.93	-18.0	-13.5	-0.98	10.1	-21.9	-8.64	0.49	8.94	27.2	-1.45	-9.56	-21.5	-9.24	-6.92	-8.45	1.80	0.63	0.17	0.94	3.70	-0.01	-0.7	0.01	-10.4	-1.18	-1.03	1.92	0.32	102	-101	2.66	1.11	-7.64	0.86	2.05	-2.23	0.91	-0.25	1.50	16.0	5.81	18.3	25.3	21.4	0.23	-2.46	31.5	-0.65	2.64	-5.15	2.38	64.0	2.45
Cash at period end	13.3	—	19.7	15.3	13.6	23.4	27.5	29.0	33.2	47.0	50.1	53.6	31.1	33.7	27.4	22.2	30.5	26.8	28.9	29.8	36.8	29.8	56.0	63.7	63.7	39.9	40.5	46.8	39.6	41.6	44.3	53.9	81.2	77.1	45.7	53.8	69.6	46.7	52.1	56.9	69.7	57.7	173	79.8	96.3	94.6	80.0	82.7	87.8	71.9	59.5	51.7	50.7	50.0	37.6	33.7	33.1	27.0	26.4	30.1	83.2	58.0	65.6	62.9	82.0	120	104

Profitability

Quarterly · %

Gross margin 71.0% Operating margin -3.9% Net margin -7.5%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2009Q4	2010Q1	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Gross margin	74.6%	76.5%	76.1%	76.8%	77.3%	76.0%	75.8%	75.1%	76.8%	77.0%	80.2%	80.5%	83.5%	77.4%	79.4%	74.2%	69.4%	77.7%	74.8%	75.0%	78.6%	78.5%	78.3%	76.4%	79.5%	77.6%	78.4%	79.8%	78.5%	78.0%	78.7%	77.5%	79.8%	77.8%	79.5%	78.5%	78.8%	78.3%	77.7%	78.1%	78.4%	77.7%	68.3%	76.3%	75.3%	75.5%	77.4%	74.8%	73.4%	73.4%	73.2%	73.2%	73.0%	63.0%	63.9%	65.1%	68.2%	67.5%	67.8%	68.7%	69.0%	62.8%	68.7%	72.2%	71.1%	70.9%	71.0%
Operating margin	11.7%	—	14.8%	13.7%	11.7%	-18.7%	12.9%	15.9%	5.4%	15.4%	17.2%	18.8%	22.9%	4.0%	9.0%	-16.8%	6.0%	2.4%	6.6%	6.4%	3.9%	-8.0%	4.9%	4.1%	7.0%	7.2%	-2.5%	9.4%	6.8%	5.8%	7.3%	8.6%	15.3%	7.2%	6.3%	3.5%	10.2%	-4.1%	0.4%	-16.6%	3.4%	6.5%	-28.7%	3.8%	3.1%	-2.8%	3.5%	-0.3%	-7.5%	-2.9%	5.6%	-5.1%	-9.0%	-34.1%	-19.6%	-13.3%	-9.1%	-15.6%	-12.5%	-9.6%	-5.3%	-25.2%	-7.9%	-8.3%	0.2%	-7.3%	-3.9%
Net margin	—	12.6%	7.2%	6.1%	5.5%	-25.7%	6.9%	8.6%	8.2%	8.4%	9.4%	6.6%	18.3%	2.1%	-2.4%	-21.4%	-7.4%	-0.8%	-0.7%	0.5%	-5.8%	-9.3%	3.5%	-1.4%	3.2%	4.0%	-7.1%	10.1%	-3.0%	-2.6%	3.5%	3.3%	1.3%	4.8%	0.8%	-1.1%	7.3%	0.8%	-0.5%	-35.7%	9.6%	24.5%	-25.2%	4.2%	-8.0%	-5.5%	2.0%	-1.9%	-26.2%	-4.2%	2.1%	-9.4%	-5.8%	-34.8%	-21.1%	-15.7%	-11.1%	-19.1%	-16.8%	-13.9%	-13.5%	-27.4%	-6.9%	-11.1%	-1.0%	-10.6%	-7.5%

Returns & leverage

Quarterly · %

ROE -13.9% ROA -7.2% Debt ratio 50.8%

ROE / ROA = trailing four-quarter net income ÷ average equity / total assets (annual mode: the year’s net income ÷ average of opening and closing). Not computed when the denominator is zero or negative.

Show table：Returns & leverage

Item	2009Q4	2010Q1	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
ROE	—	—	—	—	16.3%	-3.4%	-3.1%	-1.8%	-0.3%	15.5%	14.7%	12.5%	14.4%	11.2%	8.0%	0.1%	-7.9%	-8.6%	-9.0%	-2.9%	-2.2%	-4.7%	-3.4%	-4.0%	-0.9%	3.3%	-0.5%	3.4%	1.1%	-1.3%	2.9%	0.5%	2.2%	4.9%	3.8%	2.1%	4.4%	2.9%	2.4%	-9.9%	-8.6%	-1.1%	-6.2%	7.1%	0.7%	-8.2%	-2.3%	-4.2%	-11.1%	-10.7%	-10.5%	-13.0%	-5.9%	-15.3%	-24.1%	-28.7%	-32.4%	-20.5%	-20.3%	-20.9%	-22.9%	-27.8%	-24.6%	-24.6%	-19.3%	-13.4%	-13.9%
ROA	—	—	—	—	7.3%	-1.5%	-1.4%	-0.8%	-0.2%	7.0%	8.0%	7.1%	8.6%	6.8%	5.5%	0.1%	-6.0%	-6.7%	-6.5%	-2.1%	-1.7%	-3.6%	-2.5%	-2.9%	-0.7%	2.5%	-0.4%	2.5%	0.8%	-0.9%	2.1%	0.4%	1.6%	3.7%	2.8%	1.6%	3.2%	2.1%	1.7%	-6.8%	-5.9%	-0.8%	-4.0%	4.8%	0.5%	-5.8%	-1.5%	-2.9%	-7.7%	-7.6%	-7.7%	-9.6%	-4.2%	-11.1%	-17.3%	-20.1%	-21.9%	-13.9%	-13.5%	-13.4%	-13.9%	-16.6%	-14.4%	-14.0%	-10.6%	-7.0%	-7.2%
Debt ratio	—	—	—	—	50.2%	57.4%	54.0%	52.6%	54.7%	52.2%	36.0%	33.2%	20.9%	20.1%	24.9%	25.8%	26.6%	24.2%	29.7%	25.8%	23.8%	24.9%	23.5%	26.1%	27.5%	24.1%	29.2%	27.4%	29.2%	24.7%	24.7%	26.1%	26.8%	23.4%	27.6%	28.2%	28.1%	28.3%	28.9%	35.6%	33.9%	28.0%	42.1%	31.4%	32.1%	30.9%	27.8%	27.1%	29.3%	27.4%	25.9%	25.8%	26.6%	27.6%	29.0%	32.0%	35.3%	37.0%	38.1%	39.4%	43.7%	44.3%	45.3%	46.9%	47.1%	50.9%	50.8%

EPS

Quarterly · US$

EPS US$-0.39

Show table：EPS

Item	2009Q4	2010Q1	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
EPS（US$）	1.42	0.99	0.57	0.48	0.44	-2.00	0.54	0.66	0.65	0.63	0.58	0.39	1.04	0.11	-0.12	-1.10	-0.43	-0.04	-0.04	0.02	-0.31	-0.45	0.19	-0.07	0.18	0.21	-0.41	0.54	-0.18	-0.15	0.21	0.19	0.08	0.27	0.05	-0.07	0.46	0.05	-0.03	-2.14	0.60	1.32	-0.96	0.24	-0.48	-0.30	0.12	-0.11	-1.67	-0.22	0.12	-0.53	-0.35	-1.71	-1.07	-0.77	-0.59	-0.95	-0.88	-0.71	-0.75	-1.35	-0.36	-0.57	-0.05	-0.52	-0.39

Revenue & profit

Year-to-date · In mn (USD)

Revenue 408 mn Net income -36.7 mn

Year-to-date = summed from the first quarter of the fiscal year; balance-sheet items are period-end balances.

Balance sheet

Year-to-date · In mn (USD)

Total assets 873 mn Total liabilities 444 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Cash flow

Year-to-date · In mn (USD)

Operating -23.8 mn Investing -23.2 mn Financing 66.4 mn

Positive = cash in, negative = cash out.

Profitability

Year-to-date · %

Gross margin 71.0% Operating margin -5.5% Net margin -9.0%

Gross, operating and net margin = the respective profit ÷ revenue.

Returns & leverage

Year-to-date · %

ROE -13.9% ROA -7.2% Debt ratio 50.8%

EPS

Year-to-date · US$

EPS US$-0.91

Revenue & profit

Annual · In mn (USD)

Revenue 822 mn Net income -92.2 mn

Annual = sum of four quarters of a complete fiscal year (incomplete years are omitted); balance-sheet items are year-end balances.

Show table：Income statement

Item	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	564	579	489	397	404	396	410	434	453	460	407	464	461	747	799	822
Gross profit	433	440	392	298	309	310	322	341	356	359	305	350	337	486	546	566
Operating income	—	23.7	89.8	3.61	19.6	9.26	21.2	40.8	31.2	-18.8	-6.27	-8.31	-13.3	-139	-84.6	-81.4
Net income	44.2	-1.07	51.3	-27.9	-6.81	-2.81	3.17	6.22	13.8	-28.5	2.52	-38.4	-19.8	-151	-126	-92.2

Balance sheet

Annual · In mn (USD)

Total assets 851 mn Total liabilities 401 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Current assets	312	405	340	280	256	212	194	252	245	261	270	270	256	420	433	417
Total assets	604	696	504	423	393	400	372	405	467	496	526	477	459	925	893	851
Current liabilities	83.5	175	68.8	66.8	66.4	82.0	83.4	79.4	85.9	84.9	104	106	83.6	165	169	170
Total liabilities	303	380	105	113	93.6	110	109	109	131	168	169	140	122	327	390	401
Equity	301	315	399	310	300	290	263	297	335	328	357	337	337	599	503	450

Cash flow

Annual · In mn (USD)

Operating 33.4 mn Investing -34.6 mn Financing -0.79 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Operating	—	64.8	11.2	67.0	51.0	43.2	44.7	53.3	49.9	32.0	74.3	18.5	-11.5	-45.8	25.8	33.4
Investing	—	-31.0	125	-31.1	-19.9	-38.4	-21.9	-16.5	-61.0	-22.9	-52.3	-23.0	-24.5	-33.1	-27.6	-34.6
Financing	—	-13.7	-139	-38.4	-20.0	25.1	-46.1	3.54	2.99	-10.7	3.25	-3.62	-0.08	65.3	50.7	-0.79
Cash at period end	13.6	33.2	31.1	30.5	36.8	63.7	39.6	81.2	69.6	69.7	96.3	87.8	50.7	33.1	83.2	82.0

Profitability

Annual · %

Gross margin 68.8% Operating margin -9.9% Net margin -11.2%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Gross margin	76.7%	76.0%	80.1%	75.0%	76.5%	78.2%	78.6%	78.5%	78.7%	78.1%	74.9%	75.3%	73.2%	65.1%	68.3%	68.8%
Operating margin	—	4.1%	18.3%	0.9%	4.9%	2.3%	5.2%	9.4%	6.9%	-4.1%	-1.5%	-1.8%	-2.9%	-18.6%	-10.6%	-9.9%
Net margin	7.8%	-0.2%	10.5%	-7.0%	-1.7%	-0.7%	0.8%	1.4%	3.0%	-6.2%	0.6%	-8.3%	-4.3%	-20.3%	-15.8%	-11.2%

Returns & leverage

Annual · %

ROE -19.3% ROA -10.6% Debt ratio 47.1%

Show table：Returns & leverage

Item	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
ROE	14.7%	-0.3%	14.4%	-7.9%	-2.2%	-0.9%	1.1%	2.2%	4.4%	-8.6%	0.7%	-11.1%	-5.9%	-32.4%	-22.9%	-19.3%
ROA	7.3%	-0.2%	8.6%	-6.0%	-1.7%	-0.7%	0.8%	1.6%	3.2%	-5.9%	0.5%	-7.7%	-4.2%	-21.9%	-13.9%	-10.6%
Debt ratio	50.2%	54.7%	20.9%	26.6%	23.8%	27.5%	29.2%	26.8%	28.1%	33.9%	32.1%	29.3%	26.6%	35.3%	43.7%	47.1%

EPS

Annual · US$

EPS US$-2.33

Show table：EPS

Item	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
EPS（US$）	2.48	-0.15	2.64	-1.54	-0.37	-0.15	0.16	0.33	0.71	-1.52	0.12	-1.96	-0.98	-4.14	-3.29	-2.33

Source: SEC EDGAR (XBRL company facts)

Annual reports by year

	10-K
2025	Open full text →
2024	Open full text →
2023	Open full text →

10-K: annual report of a US domestic issuer. Filings are the original documents hosted on SEC EDGAR — this site neither mirrors nor edits them.

FAQ

Where can I read Orthofix Medical Inc. (OFIX) annual reports?

Every year in the table above links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser without downloading anything. 3 filings are currently indexed.

What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer, with sections fixed by law: Item 1 Business, Item 1A Risk Factors, Item 7 Management's Discussion and Analysis. A 20-F is filed by foreign private issuers — Taiwanese companies with US ADRs, such as TSMC, file 20-F rather than 10-K. A 40-F applies to Canadian issuers under the MJDS.

Are earnings call materials available here?

No. Earnings calls are not SEC filings, so US pages on this site cover annual reports only. Taiwan has a mandatory investor-conference disclosure regime, and those materials are indexed under Annual Reports.

Source: US Securities and Exchange Commission (SEC) EDGAR. This site indexes public filings and links to them; it hosts no copies, offers no investment advice, and makes no warranty as to timeliness or completeness.
Back to US annual reports, or see the supply-chain maps.